JP Patent
JP6203848B2 — キナーゼ阻害剤としてのピラゾロピリミジン化合物
Assigned to プリンシピア バイオファーマ インコーポレイテッド · Expires 2017-09-27 · 9y expired
What this patent protects
Patent listed against Wayrilz.
Drugs covered by this patent
- Wayrilz (RILZABRUTINIB) · Genzyme Corp
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.